IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 82 filers reported holding IMMUNOMEDICS INC in Q3 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $184,000 | -71.1% | 20,819 | -78.8% | 0.01% | -72.2% |
| Q1 2017 | $636,000 | +243.8% | 98,262 | +72.7% | 0.02% | +350.0% |
| Q3 2016 | $185,000 | +74.5% | 56,892 | +24.2% | 0.00% | +100.0% |
| Q2 2016 | $106,000 | -25.4% | 45,821 | -19.3% | 0.00% | -50.0% |
| Q1 2016 | $142,000 | +63.2% | 56,755 | +100.8% | 0.00% | +300.0% |
| Q4 2015 | $87,000 | +117.5% | 28,259 | +20.3% | 0.00% | 0.0% |
| Q3 2015 | $40,000 | -51.2% | 23,483 | +16.2% | 0.00% | 0.0% |
| Q2 2015 | $82,000 | -28.1% | 20,201 | -32.1% | 0.00% | -50.0% |
| Q1 2015 | $114,000 | +81.0% | 29,765 | +75.6% | 0.00% | +100.0% |
| Q3 2014 | $63,000 | +43.2% | 16,953 | +40.2% | 0.00% | 0.0% |
| Q2 2014 | $44,000 | -64.8% | 12,093 | -55.7% | 0.00% | 0.0% |
| Q4 2013 | $125,000 | – | 27,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
| J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
| Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
| SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
| J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |